Matches in Wikidata for { <http://www.wikidata.org/entity/Q90354463> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q90354463 description "article scientifique publié en 2018" @default.
- Q90354463 description "artículu científicu espublizáu n'avientu de 2018" @default.
- Q90354463 description "scientific article published on 05 December 2018" @default.
- Q90354463 description "wetenschappelijk artikel" @default.
- Q90354463 description "наукова стаття, опублікована в грудні 2018" @default.
- Q90354463 name "Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments" @default.
- Q90354463 name "Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments" @default.
- Q90354463 type Item @default.
- Q90354463 label "Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments" @default.
- Q90354463 label "Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments" @default.
- Q90354463 prefLabel "Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments" @default.
- Q90354463 prefLabel "Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments" @default.
- Q90354463 P1433 Q90354463-8822AC3C-BA99-4AB7-A692-83C1FA9A4C09 @default.
- Q90354463 P1476 Q90354463-B9F3102D-A6C0-4AC0-89A0-C87FD2152349 @default.
- Q90354463 P2093 Q90354463-29FE543D-7DF1-470B-B6D8-9082A8CFAA10 @default.
- Q90354463 P2093 Q90354463-44EA1283-5794-4775-BC2C-DFE2C7F8B8BA @default.
- Q90354463 P2093 Q90354463-47B3B259-B1A3-4B4C-A994-739079ACF782 @default.
- Q90354463 P2093 Q90354463-648A005F-4C19-4103-97F7-8B53D27A6F5A @default.
- Q90354463 P2093 Q90354463-7BF55039-1C26-4B14-9EF4-212D89CD97D9 @default.
- Q90354463 P2093 Q90354463-8BC1730A-3AA0-49AA-AA21-88923158A268 @default.
- Q90354463 P2093 Q90354463-8EC29441-26BC-400E-B4B2-5ADE3AFE613A @default.
- Q90354463 P2093 Q90354463-959EC4A1-A32A-4F5F-A8BC-910F74881566 @default.
- Q90354463 P2093 Q90354463-ADAB9892-8125-4295-84FC-C08963D821ED @default.
- Q90354463 P2093 Q90354463-B52C93E0-2500-4F67-B782-AD8DCB5A36EE @default.
- Q90354463 P2093 Q90354463-C152FADD-37E4-417F-ABF7-5E5F41098644 @default.
- Q90354463 P2093 Q90354463-C4707ABE-F4B9-424D-A93B-594EDF4C0CC7 @default.
- Q90354463 P2093 Q90354463-DD34B31A-7365-4B2D-BB3D-908DB0290CCF @default.
- Q90354463 P2093 Q90354463-DF032F3E-C83A-4F51-B65E-9EB6AD18ED42 @default.
- Q90354463 P2093 Q90354463-EBA46CA6-6E1B-4B19-92E3-BE3FA5FAA906 @default.
- Q90354463 P2093 Q90354463-FFC2BBE2-8D45-47E9-918D-2533B70E4179 @default.
- Q90354463 P304 Q90354463-E8B77AAA-8EFA-48B5-BAFB-3533EA43569A @default.
- Q90354463 P31 Q90354463-657FFFD8-F96D-48E1-99AA-06C0CF3CDFE7 @default.
- Q90354463 P356 Q90354463-36D8FD9C-39C1-4173-94C3-3C598203F35A @default.
- Q90354463 P478 Q90354463-47824A2E-A7A6-4C08-B98F-447D4195BA68 @default.
- Q90354463 P577 Q90354463-5CFDB3DA-9516-4CE8-B6DC-D6DD062BF80F @default.
- Q90354463 P698 Q90354463-B52C7CA5-DF6E-4C33-853E-EF19D76808B4 @default.
- Q90354463 P921 Q90354463-C963D00A-C4D6-4435-83BA-1F0EEFF4AE90 @default.
- Q90354463 P356 J.EJCA.2018.11.005 @default.
- Q90354463 P698 30528800 @default.
- Q90354463 P1433 Q332260 @default.
- Q90354463 P1476 "Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments" @default.
- Q90354463 P2093 "A D Pinna" @default.
- Q90354463 P2093 "A D'Errico-Grigioni" @default.
- Q90354463 P2093 "A Palloni" @default.
- Q90354463 P2093 "D Malvi" @default.
- Q90354463 P2093 "F Vasuri" @default.
- Q90354463 P2093 "G Brandi" @default.
- Q90354463 P2093 "G Frega" @default.
- Q90354463 P2093 "I Garajova" @default.
- Q90354463 P2093 "L Ricciardiello" @default.
- Q90354463 P2093 "M A Barbera" @default.
- Q90354463 P2093 "M A Pantaleo" @default.
- Q90354463 P2093 "M Cescon" @default.
- Q90354463 P2093 "M Deserti" @default.
- Q90354463 P2093 "S Curti" @default.
- Q90354463 P2093 "S De Lorenzo" @default.
- Q90354463 P2093 "S Tavolari" @default.
- Q90354463 P304 "160-170" @default.
- Q90354463 P31 Q13442814 @default.
- Q90354463 P356 "10.1016/J.EJCA.2018.11.005" @default.
- Q90354463 P478 "106" @default.
- Q90354463 P577 "2018-12-05T00:00:00Z" @default.
- Q90354463 P698 "30528800" @default.
- Q90354463 P921 Q18556554 @default.